Adjuvant Chemotherapy Is Associated with Improved Survival after Esophagectomy without Induction Therapy for Node-Positive Adenocarcinoma

Howlader, 2011

Enzinger, 2003, Esophageal cancer, N Engl J Med, 349, 2241, 10.1056/NEJMra035010

Pennathur, 2008, Resection for esophageal cancer: strategies for optimal management, Ann Thorac Surg, 85, S751, 10.1016/j.athoracsur.2007.11.078

Siegel, 2012, Cancer statistics, 2012, CA Cancer J Clin, 62, 10, 10.3322/caac.20138

Dubecz, 2012, Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis, J Thorac Oncol, 7, 443, 10.1097/JTO.0b013e3182397751

Horner, 2009

Rice, 2010, Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals, Cancer, 116, 3763, 10.1002/cncr.25146

Smith, 2009, Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort, Int J Radiat Oncol Biol Phys, 74, 482, 10.1016/j.ijrobp.2008.08.046

Worni, 2014, Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008, Dis Esophagus, 27, 662, 10.1111/dote.12123

Burmeister, 2005, Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial, Lancet Oncol, 6, 659, 10.1016/S1470-2045(05)70288-6

Tepper, 2008, Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781, J Clin Oncol, 26, 1086, 10.1200/JCO.2007.12.9593

Sjoquist, 2011, Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis, Lancet Oncol, 12, 681, 10.1016/S1470-2045(11)70142-5

Schwer, 2009, Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study, Int J Radiat Oncol Biol Phys, 73, 449, 10.1016/j.ijrobp.2008.04.022

Solomon, 2010, The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma, Ann Surg Oncol, 17, 791, 10.1245/s10434-009-0819-4

van Hagen, 2012, Preoperative chemoradiotherapy for esophageal or junctional cancer, N Engl J Med, 366, 2074, 10.1056/NEJMoa1112088

Ajani, 2011, Esophageal and esophagogastric junction cancers, J Natl Compr Canc Netw, 9, 830, 10.6004/jnccn.2011.0072

Macdonald, 2001, Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction, N Engl J Med, 345, 725, 10.1056/NEJMoa010187

Smalley, 2012, Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection, J Clin Oncol, 30, 2327, 10.1200/JCO.2011.36.7136

Lee, 2012, Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial, J Clin Oncol, 30, 268, 10.1200/JCO.2011.39.1953

Sakuramoto, 2007, Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine, N Engl J Med, 357, 1810, 10.1056/NEJMoa072252

Sasako, 2011, Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer, J Clin Oncol, 29, 4387, 10.1200/JCO.2011.36.5908

Bang, 2012, Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial, Lancet, 379, 315, 10.1016/S0140-6736(11)61873-4

Noh, 2013, Adjuvant capecitabine and oxaliplatin (XELOX) for gastric cancer after D2 gastrectomy: final results from the CLASSIC trial, Ann Oncol, 24, iv14, 10.1093/annonc/mdt201.7

Atkins, 2004, Reducing hospital morbidity and mortality following esophagectomy, Ann Thorac Surg, 78, 1170, 10.1016/j.athoracsur.2004.02.034

Bailey, 2003, Outcomes after esophagectomy: a ten-year prospective cohort, Ann Thorac Surg, 75, 217, 10.1016/S0003-4975(02)04368-0

Chang, 2008, Outcomes after transhiatal and transthoracic esophagectomy for cancer, Ann Thorac Surg, 85, 424, 10.1016/j.athoracsur.2007.10.007

Rentz, 2003, Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients, J Thorac Cardiovasc Surg, 125, 1114, 10.1067/mtc.2003.315

Dimick, 2005, National trends in outcomes for esophageal resection, Ann Thorac Surg, 79, 212, 10.1016/j.athoracsur.2004.06.044

Ra, 2008, Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model, Ann Surg Oncol, 15, 1577, 10.1245/s10434-008-9867-4

Wright, 2009, Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model, J Thorac Cardiovasc Surg, 137, 587, 10.1016/j.jtcvs.2008.11.042

de Boer, 2004, Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus, J Clin Oncol, 22, 4202, 10.1200/JCO.2004.11.102

Moorcraft, 2014, Adjuvant or neoadjuvant therapy for operable esophagogastric cancer, Gastric Cancer

Crabtree, 2013, Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database, Ann Thorac Surg, 96, 382, 10.1016/j.athoracsur.2013.03.093

Crabtree, 2011, Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival, Ann Thorac Surg, 91, 1509, 10.1016/j.athoracsur.2011.01.063

DeWitt, 2005, Endoscopic ultrasound for esophageal and gastroesophageal junction cancer: impact of increased use of primary neoadjuvant therapy on preoperative locoregional staging accuracy, Dis Esophagus, 18, 21, 10.1111/j.1442-2050.2005.00444.x

Kutup, 2007, Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer, Endoscopy, 39, 715, 10.1055/s-2007-966655

Pech, 2010, Accuracy of endoscopic ultrasound in preoperative staging of esophageal cancer: results from a referral center for early esophageal cancer, Endoscopy, 42, 456, 10.1055/s-0029-1244022

Stiles, 2011, Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease, Ann Thorac Surg, 92, 491, 10.1016/j.athoracsur.2011.04.004